Workflow
KORE(KORE) - 2025 Q1 - Quarterly Results
2025-05-15 20:19
Revenue Performance - Revenue for Q4 2024 was $73.3 million, a 1.1% increase from $72.5 million in Q4 2023, driven by a $1.1 million growth in IoT Connectivity revenue[5] - Full year revenue totaled $286.1 million, up $9.5 million or 3.4% from $276.6 million in 2023, with IoT Connectivity revenue increasing by $24.5 million to $226.9 million[9] - KORE's total revenue for the year ended December 31, 2024, was $146,076,000, down from $167,042,000 in 2023[38] - The company expects revenue for 2025 to be in the range of $288 million to $298 million[14] Financial Loss and Improvement - Net loss for Q4 2024 improved to $25.4 million, a reduction of 24.6% compared to $33.7 million in Q4 2023[9] - KORE Group Holdings reported a net loss of $25,448,000 for Q4 2024, an improvement from a net loss of $33,692,000 in Q4 2023[38] - The company incurred a goodwill impairment loss of $65,861,000 for the year ended December 31, 2024[38] Cash Flow and EBITDA - Adjusted EBITDA for Q4 2024 was $14.0 million, a slight increase of 1.1% from $13.8 million in Q4 2023[9] - Adjusted EBITDA for Q4 2024 was $13,976,000, slightly up from $13,824,000 in Q4 2023[38] - Free Cash Flow for Q4 2024 was $1.6 million, a significant improvement from a negative $15.5 million in Q4 2023[9] - Free cash flow for Q4 2024 was $1,562,000, compared to a negative free cash flow of $15,546,000 in Q4 2023[39] - Total cash provided by operating activities for Q4 2024 was $2,840,000, a significant recovery from a cash used of $10,912,000 in Q4 2023[39] Operational Metrics - The total number of IoT Connections increased by 1.2 million to 19.7 million by the end of 2024[4] - The Dollar-Based Net Expansion Rate (DBNER) for the twelve months ending December 31, 2024, was 95%, down from 96% in the previous year[11] - KORE's average revenue per user (ARPU) is a key metric for assessing revenue generation per connection, calculated on a quarterly basis[33][34] Restructuring and Future Outlook - KORE completed its restructuring plan, resulting in over $20 million in annual run-rate savings[5] - Notable new business wins in Q4 included closed-won Total Contract Value (TCV) of $29.3 million, with $9.4 million related to Connectivity[13] - The company anticipates future revenue growth and operational efficiency improvements as part of its restructuring plan[35] - KORE's integration-related restructuring costs for the year were $19,159,000, compared to $16,532,000 in 2023[38] - The company reported a change in fair value of warrant liability of $2,309,000 for Q4 2024[38]
Bio-Path(BPTH) - 2025 Q1 - Quarterly Report
2025-05-15 20:18
Table of Contents (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission file number: 001-36333 Bio-Path Holdings, Inc. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ...
Aileron Therapeutics(ALRN) - 2025 Q1 - Quarterly Results
2025-05-15 20:18
Financial Performance - The net loss for Q1 2025 was $5.5 million, compared to a net loss of $7.1 million in Q1 2024, representing a 22.5% improvement [8]. - The basic and diluted net loss per share for Q1 2025 was $0.25, down from $0.86 in Q1 2024 [8]. - Net loss for the three months ended March 31, 2025, was $5,501,000, an improvement from a net loss of $7,113,000 in the same period of 2024 [14]. - Net cash used in operating activities increased to $6,175,000 in Q1 2025, compared to $5,271,000 in Q1 2024 [14]. - Stock-based compensation expense rose to $264,000 in Q1 2025, compared to $150,000 in Q1 2024 [14]. Cash Position - Cash and cash equivalents as of March 31, 2025, were $7.4 million, down from $12.9 million as of December 31, 2024 [8]. - Cash, cash equivalents, and restricted cash at the end of the period totaled $7,428,000, down from $12,067,000 at the end of Q1 2024 [14]. - The company reported a net decrease in cash, cash equivalents, and restricted cash of $5,437,000 during the period [14]. - Cash and cash equivalents at the end of the period were $7,428,000, compared to $12,042,000 in Q1 2024 [14]. Expenses - Research and Development (R&D) expenses for Q1 2025 were $3.1 million, a decrease of 11.6% from $3.5 million in Q1 2024 [8]. - General and Administrative (G&A) expenses for Q1 2025 were $2.5 million, down 33.3% from $3.7 million in Q1 2024 [8]. - Accounts payable decreased to $238,000 in Q1 2025, down from $966,000 in Q1 2024 [14]. - Other assets showed a significant decrease, with a net change of $(764,000) in Q1 2025 compared to an increase of $1,301,000 in Q1 2024 [14]. Corporate Developments - The RENEW Phase 2 trial of LTI-03 in idiopathic pulmonary fibrosis (IPF) has been initiated, with approximately 120 patients expected to be enrolled in two cohorts [3]. - The company plans to share topline interim data from the RENEW trial in the first half of 2026 [2]. - Rein completed warrant exercise and private placement transactions in April 2025, raising approximately $5.28 million [5]. - Two patents covering the novel formulation and administration methods of LTI-03 were granted on April 22, 2025 [5]. - Rein's common stock began trading under the Nasdaq ticker symbol "RNTX" on January 13, 2025, following a rebranding [5]. Stock Transactions - Proceeds from the issuance of common stock, net of offering costs, amounted to $737,000 in Q1 2025 [14]. - There was a conversion of Series X non-voting convertible preferred stock into common stock shares valued at $44,826,000 in the previous period [14].
iPower (IPW) - 2025 Q3 - Quarterly Report
2025-05-15 20:17
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ Commission File Number 001-40391 iPower Inc. (Exact name of registrant as specified in its charter) (State or ...
BYTE Acquisition (BYTS) - 2025 Q1 - Quarterly Results
2025-05-15 20:17
Airship AI Reports First Quarter 2025 Financial Results First Quarter 2025 Net Revenues of $5.5 Million, Gross Profit of $2.2 Million and Gross Margin of 40% Increased Investments In Our People And Digital Transformation Will Enable Us To Stay Resilient and Ready In A Rapidly Changing Marketplace EX-99.1 2 airsp_ex991.htm PRESS RELEASE EXHIBIT 99.1 Redmond, WA – May 15, 2025– Airship AI Holdings, Inc. (NASDAQ: AISP) ("Airship AI" or the "Company"), a leader in AI- driven video, sensor, and data management s ...
AIRSHIP(AISP) - 2025 Q1 - Quarterly Results
2025-05-15 20:17
EX-99.1 2 airsp_ex991.htm PRESS RELEASE EXHIBIT 99.1 Airship AI Reports First Quarter 2025 Financial Results First Quarter 2025 Net Revenues of $5.5 Million, Gross Profit of $2.2 Million and Gross Margin of 40% Redmond, WA – May 15, 2025– Airship AI Holdings, Inc. (NASDAQ: AISP) ("Airship AI" or the "Company"), a leader in AI- driven video, sensor, and data management surveillance solutions, today reported its financial and operational results for the first quarter ended March 31, 2025. Q1 2025 Financial Hi ...
Baird Medical Investment Holdings Ltd.(BDMD) - 2024 Q4 - Annual Report
2025-05-15 20:17
FORM 20-F (Mark One) ☐REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report Table of Contents UNITE ...
Permianville Royalty Trust(PVL) - 2025 Q1 - Quarterly Report
2025-05-15 20:16
Financial Performance - The Trust's gross profits for Q1 2025 were $10,572,381, a decrease of 7% compared to $11,393,715 in Q1 2024[82] - The Trust reported a net loss of $3,023,619 for Q1 2025, compared to a profit of $211,715 in Q1 2024, marking a 1,528% decrease[82] - The net loss attributable to the Underlying Properties for the three months ended March 31, 2025 was $(3.0) million, a decrease of $3.2 million from a profit of $0.2 million in the same period in 2024[84] Revenue Breakdown - Oil sales decreased by 12% to $8,530,705, while natural gas sales increased by 21% to $2,041,676[82] - Oil sales decreased by $1.2 million due to a $0.1 million decrease in produced volumes and a $1.1 million decrease in realized prices, with the average oil price received dropping by 11%[84] - Natural gas sales increased by $0.4 million, driven by a $1.1 million increase in produced volumes, although realized prices fell by 27%[84] Operating Expenses - Direct operating expenses increased by 22% to $13,596,000, driven by a 133% rise in development expenses to $7,157,000[82] - Lease operating expenses decreased by $1.9 million compared to the same period in 2024, while development expenses increased by $4.1 million due to higher drilling and completion costs[84] - Compression, gathering, and transportation costs increased by $0.4 million due to new wells coming online during the three months ended March 31, 2025[84] Production Volumes - For the three months ended March 31, 2025, oil production volumes decreased by 1% to 114,380 Bbls compared to 115,343 Bbls in 2024, while natural gas production volumes increased by 66% to 1,180,460 Mcf from 711,124 Mcf[84] Cash and Reserves - The Trust experienced a shortfall of approximately $1.4 million as of March 31, 2025, due to direct operating and development expenses exceeding cash receipts[82] - As of March 31, 2025, the Trust had cash of $2,216,799 available for future expenses, compared to $2,193,787 as of December 31, 2024[88] - The Trustee has withheld $1,241,386 toward a cash reserve for future liabilities as of March 31, 2025, with no amounts withheld during the three months ended March 31, 2025 due to a Net Profits Interest shortfall[87] - The Trust has a $1.2 million letter of credit available for administrative expenses if cash on hand is insufficient[88] Future Outlook - The Sponsor expects capital expenditures for 2025 to be revised to a range of $10.0 million to $15.0 million, up from the previous range of $7.0 million to $13.0 million[74] - The Sponsor continues to maintain cash reserves for future development expenses despite the current macroeconomic uncertainties[72] Market Conditions - Oil prices fluctuated between $57 and $80 per barrel from December 2024 to May 2025, impacting budget planning for several companies[73] - Natural gas prices ranged from $2.93 to $4.49 per MMBtu during the same period, reflecting volatility in the market[73] Development Activity - Development activity on the Underlying Properties increased over 130% in Q1 2025 compared to the same period in 2024[72] - The Trust has not borrowed any funds since its formation and has no current plans to authorize borrowing[88]
BYTE Acquisition (BYTS) - 2025 Q1 - Quarterly Report
2025-05-15 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to _____________ Commission File No. 001-40222 Airship AI Holdings, Inc. (Exact name of registrant as specified in its charter) (State or other jur ...
AIRSHIP(AISP) - 2025 Q1 - Quarterly Report
2025-05-15 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Commission File No. 001-40222 Airship AI Holdings, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 93-4974766 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 19 ...